# Matt Krueger

> Matt Krueger is the Chief Executive Officer of Caresyntax, an AI-powered surgical intelligence platform used in 4,200+ operating rooms worldwide and supporting over 3 million surgical procedures annually. A decade-long veteran of the company, Krueger rose through roles including SVP & GM for the Americas & ANZ, Chief Commercial Officer, Chief Customer Officer, and President before being elevated to CEO in July 2025. With 18+ years in medical devices and healthcare technology - including stints at Hill-Rom and TRUMPF - he has been a primary architect of Caresyntax's expansion and its consistent 50%+ organic revenue growth trajectory.

- **Role:** CEO at Caresyntax
- **Organizations:** Caresyntax, Hill-Rom, TRUMPF
- **Nationality:** American
- **Education:** Bachelor of Business Administration (BBA), University of Notre Dame
- **Known for:** Led expansion of Caresyntax to 4,200+ operating rooms globally, Drove 50%+ organic revenue growth consistently during tenure as President, Key architect of Caresyntax's $100M Series C funding round (August 2024)

## Career timeline

- **~2006-2014** — Various roles at Hill-Rom, including Director of Enterprise Accounts and VP of Market Development
- **~2013-2015** — Role at TRUMPF in medical devices
- **~2015** — Joined Caresyntax as SVP & General Manager for the Americas & ANZ
- **~2018** — Promoted to Chief Commercial Officer at Caresyntax
- **~2020** — Named Chief Customer Officer & EVP of Operations at Caresyntax
- **~2022** — Elevated to President of Caresyntax
- **2025-07-16** — Appointed Chief Executive Officer of Caresyntax

## Achievements

- Led expansion of Caresyntax to 4,200+ operating rooms globally
- Drove 50%+ organic revenue growth consistently during tenure as President
- Key architect of Caresyntax's $100M Series C funding round (August 2024)
- Built out Americas & ANZ commercial operations from the ground up
- Oversaw partnerships with major hospital systems and technology companies
- Helped grow Caresyntax to supporting 3+ million surgical procedures annually

## Latest updates

- **2025-07** — Appointed CEO of Caresyntax, succeeding co-founders Dennis Kogan and Bjoern von Siemens
- **2024-08** — Caresyntax closed a $100M Series C funding round under Krueger's leadership as President

## Links

- Website: https://caresyntax.com
- LinkedIn: http://www.linkedin.com/in/matt-krueger-500773

---

Profile page: https://yespress.io/matt-krueger
Published by YesPress — https://yespress.io
Last updated: 2026-05-25